Robitussin Cough Medicine with DXM

Case Name
(Date)
Bell et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC et al.
21-cv-9454, C.D. Cal.
(Dec. 2021)
Product/Service Robitussin cough medicine with dextromethorphan hydrobromide (DXM)
Allegations Falsely marketing medicine as “Non-Drowsy” when the active ingredient causes drowsiness
Status Pending
Print Friendly, PDF & Email

Tags:



Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker



  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases